tetano
Editor, Senior Moderator
Vaccine. 2016 Nov 25. pii: S0264-410X(16)31120-3. doi: 10.1016/j.vaccine.2016.11.058. [Epub ahead of print]
[h=1]Structural-based designed modular capsomere comprising HA1 for low-cost poultry influenza vaccination.[/h] Waneesorn J[SUP]1[/SUP], Wibowo N[SUP]1[/SUP], Bingham J[SUP]2[/SUP], Middelberg AP[SUP]1[/SUP], Lua LH[SUP]3[/SUP].
[h=3]Author information[/h]
[h=3]Abstract[/h] Highly pathogenic avian influenza (HPAI) viruses cause a severe and lethal infection in domestic birds. The increasing number of HPAI outbreaks has demonstrated the lack of capabilities to control the rapid spread of avian influenza. Poultry vaccination has been shown to not only reduce the virus spread in animals but also reduce the virus transmission to humans, preventing potential pandemic development. However, existing vaccine technologies cannot respond to a new virus outbreak rapidly and at a cost and scale that is commercially viable for poultry vaccination. Here, we developed modular capsomere, subunits of virus-like particle, as a low-cost poultry influenza vaccine. Modified murine polyomavirus (MuPyV) VP1 capsomere was used to present structural-based influenza Hemagglutinin (HA1) antigen. Six constructs of modular capsomeres presenting three truncated versions of HA1 and two constructs of modular capsomeres presenting non-modified HA1 have been generated. These modular capsomeres were successfully produced in stable forms using Escherichia coli, without the need for protein refolding. Based on ELISA, this adjuvanted modular capsomere (CaptHA1-3C) induced strong antibody response (almost 10[SUP]5[/SUP]endpoint titre) when administered into chickens, similar to titres obtained in the group administered with insect cell-based HA1 proteins. Chickens that received adjuvanted CaptHA1-3C followed by challenge with HPAI virus were fully protected. The results presented here indicate that this platform for bacterially-produced modular capsomere could potentially translate into a rapid-response and low-cost vaccine manufacturing technology suitable for poultry vaccination.
Copyright © 2016. Published by Elsevier Ltd.
[h=4]KEYWORDS:[/h] Capsomere; Influenza; Polyomavirus; Poultry; Vaccine
PMID: 27894719 DOI: 10.1016/j.vaccine.2016.11.058
[PubMed - as supplied by publisher]
[h=1]Structural-based designed modular capsomere comprising HA1 for low-cost poultry influenza vaccination.[/h] Waneesorn J[SUP]1[/SUP], Wibowo N[SUP]1[/SUP], Bingham J[SUP]2[/SUP], Middelberg AP[SUP]1[/SUP], Lua LH[SUP]3[/SUP].
[h=3]Author information[/h]
[h=3]Abstract[/h] Highly pathogenic avian influenza (HPAI) viruses cause a severe and lethal infection in domestic birds. The increasing number of HPAI outbreaks has demonstrated the lack of capabilities to control the rapid spread of avian influenza. Poultry vaccination has been shown to not only reduce the virus spread in animals but also reduce the virus transmission to humans, preventing potential pandemic development. However, existing vaccine technologies cannot respond to a new virus outbreak rapidly and at a cost and scale that is commercially viable for poultry vaccination. Here, we developed modular capsomere, subunits of virus-like particle, as a low-cost poultry influenza vaccine. Modified murine polyomavirus (MuPyV) VP1 capsomere was used to present structural-based influenza Hemagglutinin (HA1) antigen. Six constructs of modular capsomeres presenting three truncated versions of HA1 and two constructs of modular capsomeres presenting non-modified HA1 have been generated. These modular capsomeres were successfully produced in stable forms using Escherichia coli, without the need for protein refolding. Based on ELISA, this adjuvanted modular capsomere (CaptHA1-3C) induced strong antibody response (almost 10[SUP]5[/SUP]endpoint titre) when administered into chickens, similar to titres obtained in the group administered with insect cell-based HA1 proteins. Chickens that received adjuvanted CaptHA1-3C followed by challenge with HPAI virus were fully protected. The results presented here indicate that this platform for bacterially-produced modular capsomere could potentially translate into a rapid-response and low-cost vaccine manufacturing technology suitable for poultry vaccination.
Copyright © 2016. Published by Elsevier Ltd.
[h=4]KEYWORDS:[/h] Capsomere; Influenza; Polyomavirus; Poultry; Vaccine
PMID: 27894719 DOI: 10.1016/j.vaccine.2016.11.058
[PubMed - as supplied by publisher]